Actively Recruiting
Levels of Visfatin/NAMPT in Human Milk
Led by Paolo Manzoni Study Group · Updated on 2024-11-14
30
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
Sponsors
P
Paolo Manzoni Study Group
Lead Sponsor
U
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Collaborating Sponsor
AI-Summary
What this Trial Is About
Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.
CONDITIONS
Official Title
Levels of Visfatin/NAMPT in Human Milk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy male and female infants born after 37 weeks' gestation without congenital abnormalities
- Maternal hospitalization
- Signed informed consent form by the patient
You will not qualify if you...
- Refusal to participate in the study
- Presence of hypogalactia or agalactia in the mother
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale degli Infermi - ASL BI
Ponderano, BI, Italy, 13875
Actively Recruiting
Research Team
P
Paolo Manzoni, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here